UTI

SEC source: 0001209191-18-050160 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 703,828

F1 · shares: Vesting of Restricted Stock granted on 09/04/2014. Shares withheld to satisfy tax liability.

SEC source: 0001209191-18-050158 · doc4.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,080

F1 · shares: Vesting of Restricted Stock granted on 09/04/2014. Shares withheld to satisfy tax liability.

SEC source: 0001209191-18-050151 · doc4.xml · nonDerivative · entry 1

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,668

F1 · shares: Vesting of Restricted Stock granted on 09/04/2014. Shares withheld to satisfy tax liability.

SEC source: 0001209191-18-047179 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 711,885

F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2018.

SEC source: 0001209191-18-037829 · doc4.xml · nonDerivative · entry 1

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,190

F1 · shares: Vesting of Restricted Stock Units granted on 06/09/2015. Shares withheld to satisfy tax liability.

SEC source: 0001209191-18-037826 · doc4.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Campus Ops & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 183,701

F1 · shares: Vesting of Restricted Stock Units granted on 06/09/2015. Shares withheld to satisfy tax liability.

SEC source: 0001209191-18-018275 · doc4.xml · nonDerivative · entry 1

PENSKE ROGER S · CIK 0000942439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,447

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-018266 · doc4.xml · nonDerivative · entry 1

CONRAD A CONRAD · CIK 0001181846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,300

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-018286 · doc4.xml · nonDerivative · entry 1

WHITE JOHN C · CIK 0001272479 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,635

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-018282 · doc4.xml · nonDerivative · entry 1

TRAMMELL KENNETH R · CIK 0001239782 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,819

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-018280 · doc4.xml · nonDerivative · entry 1

SRERE LINDA J · CIK 0001193863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,300

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-018273 · doc4.xml · nonDerivative · entry 1

Paige Roderick R · CIK 0001368337 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,751

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-018269 · doc4.xml · nonDerivative · entry 1

DEVINCENZI ROBERT THOMAS · CIK 0001226186 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,059

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-018261 · doc4.xml · nonDerivative · entry 1

Blaszkiewicz David · CIK 0001536971 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,364

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-018257 · doc4.xml · nonDerivative · entry 1

LENNOX WILLIAM J JR · CIK 0001597376 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,669

F1 · shares: The award was approved by the Compensation Committee of UTI's Board of Directors and UTI's Board of Directors on March 7, 2018.

SEC source: 0001209191-18-017254 · doc4.xml · nonDerivative · entry 1

Jameson Piper P · CIK 0001534143 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,979

F1 · shares: Vesting of Restricted Stock Units granted on 3/1/2017, shares withheld to satisfy tax liability.

SEC source: 0001209191-18-004076 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 710,061

F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2017.

SEC source: 0001209191-17-066171 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 703,562

F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.51 to $2.57, inclusive. The reporting person undertakes to provide to Universal Technical Institute, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-17-065449 · doc4.xml · nonDerivative · entry 1

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,820

F1 · shares: Vesting of Restricted Stock Units granted on 12/7/2016. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-064556 · doc4.xml · derivative · entry 3

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2020-12-05

F3 · derivative.exercise_price: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.underlying: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-064556 · doc4.xml · derivative · entry 2

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,752

Underlying: Common Stock · 17,752 shares

Expires 2020-12-05

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-064556 · doc4.xml · nonDerivative · entry 1

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,197

F1 · shares: The Board of Directors approved the grant on December 5, 2017. The restricted stock units vest in three equal annual installments.

SEC source: 0001209191-17-064553 · doc4.xml · derivative · entry 4

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2020-12-05

F3 · derivative.exercise_price: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.underlying: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-064553 · doc4.xml · derivative · entry 3

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,758

Underlying: Common Stock · 88,758 shares

Expires 2020-12-05

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-064553 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 696,882

F1 · shares: The Board of Directors approved the grant on December 5, 2017. The restricted stock units vest in three equal annual installments.

SEC source: 0001209191-17-064555 · doc4.xml · derivative · entry 4

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2020-12-05

F3 · derivative.exercise_price: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.underlying: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-064555 · doc4.xml · derivative · entry 3

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,737

Underlying: Common Stock · 27,737 shares

Expires 2020-12-05

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-064555 · doc4.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,139

F1 · shares: The Board of Directors approved the grant on December 5, 2017. The restricted stock units vest in three equal annual installments.

SEC source: 0001209191-17-064554 · doc4.xml · derivative · entry 3

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2020-12-05

F3 · derivative.exercise_price: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.underlying: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-064554 · doc4.xml · derivative · entry 2

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,737

Underlying: Common Stock · 27,737 shares

Expires 2020-12-05

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-064554 · doc4.xml · nonDerivative · entry 1

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,803

F1 · shares: The Board of Directors approved the grant on December 5, 2017. The restricted stock units vest in three equal annual installments.

SEC source: 0001209191-17-064551 · doc4.xml · derivative · entry 3

Jameson Piper P · CIK 0001534143 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2020-12-05

F3 · derivative.exercise_price: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.underlying: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-064551 · doc4.xml · derivative · entry 2

Jameson Piper P · CIK 0001534143 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,737

Underlying: Common Stock · 27,737 shares

Expires 2020-12-05

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-064551 · doc4.xml · nonDerivative · entry 1

Jameson Piper P · CIK 0001534143 · EVP & Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,817

F1 · shares: The Board of Directors approved the grant on December 5, 2017. The restricted stock units vest in three equal annual installments.

SEC source: 0001209191-17-064550 · doc4.xml · derivative · entry 3

Grant Jerome Alan · CIK 0001723537 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2020-12-05

F3 · derivative.exercise_price: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.underlying: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-064550 · doc4.xml · derivative · entry 2

Grant Jerome Alan · CIK 0001723537 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,474

Underlying: Common Stock · 55,474 shares

Expires 2020-12-05

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-064550 · doc4.xml · nonDerivative · entry 1

Grant Jerome Alan · CIK 0001723537 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,379

F1 · shares: The Board of Directors approved the grant on December 5, 2017. The restricted stock units vest in three equal annual installments.

SEC source: 0001209191-17-064546 · doc4.xml · derivative · entry 3

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Cash · Not disclosed shares

Expires 2020-12-05

F3 · derivative.exercise_price: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.exercise_date: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

F3 · derivative.underlying: Represents a contingent right to receive cash, 50% of which vest based on the 2-year compound annual TSR and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The amount represents the maximum amount of cash that may be delivered pursuant to the award, which is 150% of the target amount of cash.

SEC source: 0001209191-17-064546 · doc4.xml · derivative · entry 2

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,737

Underlying: Common Stock · 27,737 shares

Expires 2020-12-05

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Company's common stock, 50% of which vest based on the 2-year compound annual total shareholder return ("TSR") and 50% of which vest based on the 3-year compound annual TSR. For purposes of determining the TSR, the change in the price of the Company's common stock is based upon the 30-trading day average closing stock price (i) immediately preceding the grant date at the beginning of the performance period, and (ii) immediately preceding the second or third anniversary, as applicable, of the grant date at the end of the performance period. The number represents the maximum number of shares that may be delivered pursuant to the award, which is 150% of the target number of shares.

SEC source: 0001209191-17-064546 · doc4.xml · nonDerivative · entry 1

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,355

F1 · shares: The Board of Directors approved the grant on December 5, 2017. The restricted stock units vest in three equal annual installments.

SEC source: 0001209191-17-061201 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 578,538

F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.73, inclusive. The reporting person undertakes to provide to Universal Technical Institute, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-17-057158 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 573,793

F1 · shares: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2017.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.29 to $3.49, inclusive. The reporting person undertakes to provide to Universal Technical Institute, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

SEC source: 0001209191-17-053857 · doc4.xml · nonDerivative · entry 1

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,528

F1 · shares: Vesting of Restricted Stock granted on 09/20/2012. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053862 · doc4.xml · nonDerivative · entry 1

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 568,654

F1 · shares: Vesting of Restricted Stock granted on 09/20/2012. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053877 · doc4.xml · nonDerivative · entry 1

Peterson Bryce H · CIK 0001537809 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,820

F1 · shares: Vesting of Restricted Stock granted on 09/20/2012. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053850 · doc4.xml · nonDerivative · entry 2

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Indirect · spouse

Disclosed balance after: 19,661

F1 · shares: Vesting of Restricted Stock granted on 09/20/2012. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053850 · doc4.xml · nonDerivative · entry 1

Smith Sherrell · CIK 0001371105 · EVP, Admissions and Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,156

F1 · shares: Vesting of Restricted Stock granted on 09/20/2012. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053844 · doc4.xml · nonDerivative · entry 1

Freed Chad Allen · CIK 0001319172 · EVP, Gen Counsel & Corp Dev

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,372

F1 · shares: Vesting of Restricted Stock granted on 09/20/2012. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053376 · doc4.xml · nonDerivative · entry 2

Turner Rhonda R · CIK 0001493754 · SVP People Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,522

F2 · shares: Vesting of Restricted Stock Units granted on 09/16/2015. Shares withheld to satisfy tax liability.

SEC source: 0001209191-17-053374 · doc4.xml · nonDerivative · entry 2

MCWATERS KIMBERLY J · CIK 0001272480 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 574,174

F2 · shares: Vesting of Restricted Stock Units granted on 09/16/2015. Shares withheld to satisfy tax liability.